4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-026375
President and CEO sold 19,473 shares at an average $8.93 ($173,991)
- President and CEO acquired 43,028 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KANE MATTHEW R. President and CEO | 2021-04-08 | Option exercise | +21,514 | $0.04 | $861 | 1,950,982 | D: show line 1 in the form |
| KANE MATTHEW R. President and CEO | 2021-04-08 | Sale | −9,736 | $9.00 | $87,624 | 1,941,246 | D: show line 2 in the form |
| KANE MATTHEW R. President and CEO | 2021-04-09 | Option exercise | +21,514 | $0.04 | $861 | 1,962,760 | D: show line 3 in the form |
| KANE MATTHEW R. President and CEO | 2021-04-09 | Sale | −9,737 | $8.87 | $86,367 | 1,953,023 | D: show line 4 in the form |
| Open-market sales · 19,473 sh · avg $8.93 · $173,991 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KANE MATTHEW R. President and CEO | 2021-04-08 | Option exercise · Employee Stock Option (Right to Buy) | −21,514 | 107,570 | D: show line 5 in the form | |||||
| KANE MATTHEW R. President and CEO | 2021-04-09 | Option exercise · Employee Stock Option (Right to Buy) | −21,514 | 86,056 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…